BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong L, Gopalan V, Holland O, Neuzil J. Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy. Int J Mol Sci 2020;21:E7941. [PMID: 33114695 DOI: 10.3390/ijms21217941] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Yao J, Takenaga K, Koshikawa N, Kida Y, Lin J, Watanabe T, Maru Y, Hippo Y, Yamamoto S, Zhu Y, Nagase H. Anticancer effect of a pyrrole-imidazole polyamide-triphenylphosphonium conjugate selectively targeting a common mitochondrial DNA cancer risk variant in cervical cancer cells. Int J Cancer 2023;152:962-76. [PMID: 36214789 DOI: 10.1002/ijc.34319] [Reference Citation Analysis]
2 Chen J, Sun M, Cui X, Zhang X. Ginsenoside compound K induces mitochondrial apoptosis in human hepatoma cells through Bclaf1-mediated modulation of ERK signaling. Food and Agricultural Immunology 2022;33:799-816. [DOI: 10.1080/09540105.2022.2134313] [Reference Citation Analysis]
3 Zhou J, Wang H, Wang W, Ma Z, Chi Z, Liu S. A Cationic Amphiphilic AIE Polymer for Mitochondrial Targeting and Imaging. Pharmaceutics 2022;15. [PMID: 36678732 DOI: 10.3390/pharmaceutics15010103] [Reference Citation Analysis]
4 Bachmann M, Rossa A, Varanita T, Fioretti B, Biasutto L, Milenkovic S, Checchetto V, Peruzzo R, Ahmad SA, Patel SH, Lukowski R, Edwards MJ, Ceccarelli M, Gulbins E, Zoratti M, Mattarei A, Szabo I. Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo. Cell Death Dis 2022;13:1055. [PMID: 36539400 DOI: 10.1038/s41419-022-05463-8] [Reference Citation Analysis]
5 Swargiary G, Mani S. Nanotubes and fullerene as efficient nanocarriers for delivery of mitocans to hexokinase 2: An in-silico approach. Materials Today: Proceedings 2022. [DOI: 10.1016/j.matpr.2022.11.419] [Reference Citation Analysis]
6 Youden B, Jiang R, Carrier AJ, Servos MR, Zhang X. A Nanomedicine Structure-Activity Framework for Research, Development, and Regulation of Future Cancer Therapies. ACS Nano 2022;16:17497-551. [PMID: 36322785 DOI: 10.1021/acsnano.2c06337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Patil AS, Ibrahim MK, Sathaye S, Degani MS, Pal D, Checker R, Sharma D, Sandur SK. Mitochondriotropic Derivative of Ethyl Ferulate, a Dietary Phenylpropanoid, Exhibits Enhanced Cytotoxicity in Cancer Cells via Mitochondrial Superoxide-Mediated Activation of JNK and AKT Signalling. Appl Biochem Biotechnol 2022. [DOI: 10.1007/s12010-022-04252-5] [Reference Citation Analysis]
8 Zunica ERM, Axelrod CL, Kirwan JP. Phytochemical Targeting of Mitochondria for Breast Cancer Chemoprevention, Therapy, and Sensitization. Int J Mol Sci 2022;23. [PMID: 36430632 DOI: 10.3390/ijms232214152] [Reference Citation Analysis]
9 Stuhldreier F, Schmitt L, Lenz T, Hinxlage I, Zimmermann M, Wollnitzke P, Schliehe-Diecks J, Liu Y, Jäger P, Geyh S, Teusch N, Peter C, Bhatia S, Haas R, Levkau B, Reichert AS, Stühler K, Proksch P, Stork B, Wesselborg S. The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism. Cell Death Dis 2022;13:938. [PMID: 36347842 DOI: 10.1038/s41419-022-05356-w] [Reference Citation Analysis]
10 Duncan NS, Campbell MJ, Backos DS, Li C, Rider KC, Stump S, Weaver MJ, Gajewski MP, Beall HD, Reigan P, Natale NR. 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line. Bioorganic & Medicinal Chemistry 2022;69:116911. [DOI: 10.1016/j.bmc.2022.116911] [Reference Citation Analysis]
11 Mendivil-perez M, Jimenez-del-rio M, Velez-pardo C. Polycationic peptide R7-G-Aβ25-35 selectively induces cell death in leukemia Jurkat T cells through speedy mitochondrial depolarization, and CASPASE-3 -independent mechanism. Biochemistry and Biophysics Reports 2022;31:101300. [DOI: 10.1016/j.bbrep.2022.101300] [Reference Citation Analysis]
12 Arbon D, Ženíšková K, Šubrtová K, Mach J, Štursa J, Machado M, Zahedifard F, Leštinová T, Hierro-Yap C, Neuzil J, Volf P, Ganter M, Zoltner M, Zíková A, Werner L, Sutak R. Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens. Antimicrob Agents Chemother 2022;:e0072722. [PMID: 35856666 DOI: 10.1128/aac.00727-22] [Reference Citation Analysis]
13 Kalyanaraman B, Cheng G, Hardy M. Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities. Front Oncol 2022;12:816504. [PMID: 35756631 DOI: 10.3389/fonc.2022.816504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kit O, Frantsiyants E, Shikhlyarova A, Neskubina I, Kaplieva I, Trepitaki L, Pogorelova Y, Cheryarina N, Vereskunova A, Bandovkina V, Surikova E, Maksimova N, Kotieva I, Gusareva M, Pozdnyakova V. Мitochondrial therapy of melanoma B16/F10, pathophysiological parameters of tumor regression. CM 2022. [DOI: 10.18137/cardiometry.2022.22.5661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Castelôa M, Moreira-pinto B, Benfeito S, Borges F, Fonseca BM, Rebelo I. In Vitro Effects of Mitochondria-Targeted Antioxidants in a Small-Cell Carcinoma of the Ovary of Hypercalcemic Type and in Type 1 and Type 2 Endometrial Cancer. Biomedicines 2022;10:800. [DOI: 10.3390/biomedicines10040800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Heise NV, Major D, Hoenke S, Kozubek M, Serbian I, Csuk R. Rhodamine 101 Conjugates of Triterpenoic Amides Are of Comparable Cytotoxicity as Their Rhodamine B Analogs. Molecules 2022;27:2220. [DOI: 10.3390/molecules27072220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Arbon D, Ženíšková K, Šubrtová K, Mach J, Štursa J, Machado M, Zahedifard F, Leštinová T, Hierro-yap C, Neuzil J, Volf P, Ganter M, Zoltner M, Zíková A, Werner L, Sutak R. Repurposing of mitochondria-targeted tamoxifen: Novel anti-cancer drug exhibits potent activity against major protozoan and fungal pathogens.. [DOI: 10.1101/2022.03.24.485593] [Reference Citation Analysis]
18 Hönigova K, Navratil J, Peltanova B, Polanska HH, Raudenska M, Masarik M. Metabolic tricks of cancer cells. Biochim Biophys Acta Rev Cancer 2022;:188705. [PMID: 35276232 DOI: 10.1016/j.bbcan.2022.188705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
19 Khattar KE, Safi J, Rodriguez A, Vignais M. Intercellular Communication in the Brain through Tunneling Nanotubes. Cancers 2022;14:1207. [DOI: 10.3390/cancers14051207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Yoshinaga N, Numata K. Rational Designs at the Forefront of Mitochondria-Targeted Gene Delivery: Recent Progress and Future Perspectives. ACS Biomater Sci Eng 2022;8:348-59. [PMID: 34979085 DOI: 10.1021/acsbiomaterials.1c01114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Su X, Chen Y, Wu J, Wu X, Li K, Wang X, Sun J, Wang H, Ou T. Design, synthesis, and evaluation of 9-(pyrimidin-2-yl)-9H-carbazole derivatives disrupting mitochondrial homeostasis in human lung adenocarcinoma. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Hicke FJ, Puerta A, Dinić J, Pešić M, Padrón JM, López Ó, Fernández-Bolaños JG. Straightforward access to novel mitochondriotropics derived from 2-arylethanol as potent and selective antiproliferative agents. Eur J Med Chem 2022;228:113980. [PMID: 34847410 DOI: 10.1016/j.ejmech.2021.113980] [Reference Citation Analysis]
23 Yu ZQ, Wang LM, Yang WX. How vitamin E and its derivatives regulate tumour cells via the MAPK signalling pathway?'. Gene 2022;808:145998. [PMID: 34626718 DOI: 10.1016/j.gene.2021.145998] [Reference Citation Analysis]
24 Yan X, Yao C, Fang C, Han M, Gong C, Hu D, Shen W, Wang L, Li S, Zhu S. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. Int J Biol Sci 2022;18:585-98. [PMID: 35002511 DOI: 10.7150/ijbs.65019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
25 Agrawal K, Arfin S, Mishra MK, Harihar S, Kesari KK, Roychoudhury S, Kumar D. Signaling pathways in metabolic dysregulation in solid tumors. Autophagy and Metabolism 2022. [DOI: 10.1016/b978-0-323-99879-6.00013-4] [Reference Citation Analysis]
26 Lu J, Li R, Mu B, Peng Y, Zhao Y, Shi Y, Guo L, Hai L, Wu Y. Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma. Eur J Med Chem 2021;230:114093. [PMID: 35007860 DOI: 10.1016/j.ejmech.2021.114093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Li X, Wang Y, Li M, Wang H, Dong X. Metal Complexes or Chelators with ROS Regulation Capacity: Promising Candidates for Cancer Treatment. Molecules 2021;27:148. [PMID: 35011380 DOI: 10.3390/molecules27010148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
28 Kaur P, Nagar S, Bhagwat M, Uddin M, Zhu Y, Vancurova I, Vancura A. Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells. PLoS One 2021;16:e0260400. [PMID: 34807950 DOI: 10.1371/journal.pone.0260400] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
29 Mannan A, Germon ZP, Chamberlain J, Sillar JR, Nixon B, Dun MD. Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses. Antioxidants (Basel) 2021;10:1616. [PMID: 34679751 DOI: 10.3390/antiox10101616] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zunica ERM, Axelrod CL, Cho E, Spielmann G, Davuluri G, Alexopoulos SJ, Beretta M, Hoehn KL, Dantas WS, Stadler K, King WT, Pergola K, Irving BA, Langohr IM, Yang S, Hoppel CL, Gilmore LA, Kirwan JP. Breast cancer growth and proliferation is suppressed by the mitochondrial targeted furazano[3,4-b]pyrazine BAM15. Cancer Metab 2021;9:36. [PMID: 34627389 DOI: 10.1186/s40170-021-00274-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Swargiary G, Mani S. Molecular docking and simulation studies of phytocompounds derived from Centella asiatica and Andrographis paniculata against hexokinase II as mitocan agents. Mitochondrion 2021;61:138-46. [PMID: 34606995 DOI: 10.1016/j.mito.2021.09.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Tabish TA, Hamblin MR. Mitochondria-targeted nanoparticles (mitoNANO): An emerging therapeutic shortcut for cancer. Biomaterials and Biosystems 2021;3:100023. [DOI: 10.1016/j.bbiosy.2021.100023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
33 Andreidesz K, Szabo A, Kovacs D, Koszegi B, Bagone Vantus V, Vamos E, Isbera M, Kalai T, Bognar Z, Kovacs K, Gallyas F Jr. Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines. Int J Mol Sci 2021;22:9016. [PMID: 34445722 DOI: 10.3390/ijms22169016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
34 Friedlander JE, Shen N, Zeng A, Korm S, Feng H. Failure to Guard: Mitochondrial Protein Quality Control in Cancer. Int J Mol Sci 2021;22:8306. [PMID: 34361072 DOI: 10.3390/ijms22158306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
35 Dankó T, Petővári G, Sztankovics D, Moldvai D, Raffay R, Lőrincz P, Visnovitz T, Zsiros V, Barna G, Márk Á, Krencz I, Sebestyén A. Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells. Int J Mol Sci 2021;22:8019. [PMID: 34360785 DOI: 10.3390/ijms22158019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Moindjie H, Rodrigues-Ferreira S, Nahmias C. Mitochondrial Metabolism in Carcinogenesis and Cancer Therapy. Cancers (Basel) 2021;13:3311. [PMID: 34282749 DOI: 10.3390/cancers13133311] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
37 Heise N, Hoenke S, Simon V, Deigner HP, Al-Harrasi A, Csuk R. Type and position of linkage govern the cytotoxicity of oleanolic acid rhodamine B hybrids. Steroids 2021;172:108876. [PMID: 34129861 DOI: 10.1016/j.steroids.2021.108876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Checchetto V, Leanza L, De Stefani D, Rizzuto R, Gulbins E, Szabo I. Mitochondrial K+ channels and their implications for disease mechanisms. Pharmacol Ther 2021;227:107874. [PMID: 33930454 DOI: 10.1016/j.pharmthera.2021.107874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
39 Szabo I, Zoratti M, Biasutto L. Targeting mitochondrial ion channels for cancer therapy. Redox Biol 2021;42:101846. [PMID: 33419703 DOI: 10.1016/j.redox.2020.101846] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
40 Bachmann M, Rossa A, Antoniazzi G, Biasutto L, Carrer A, Campagnaro M, Leanza L, Gonczi M, Csernoch L, Paradisi C, Mattarei A, Zoratti M, Szabo I. Synthesis and cellular effects of a mitochondria-targeted inhibitor of the two-pore potassium channel TASK-3. Pharmacol Res 2021;164:105326. [PMID: 33338625 DOI: 10.1016/j.phrs.2020.105326] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]